Medical Care

Global Neoantigen Targeted Therapy Market Research Report 2025

The global market for Neoantigen Targeted Therapy was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Neoantigen therapy is mainly through high-throughput gene sequencing and data analysis to discover individualized numerous somatic mutations in the patient"s tumor, screen out mutations that may become neoantigens as targets, and load them on antigen-producing cells (APCs), thereby It has the effect of activating T cells to recognize a variety of new antigens, and then kill tumors.
Rising prevalence of malignancies and colon cancer, patient preference for targeted therapy, and increased risk of ovarian cancer among women are key factors for increasing market revenue.
This report aims to provide a comprehensive presentation of the global market for Neoantigen Targeted Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Neoantigen Targeted Therapy.
The Neoantigen Targeted Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Neoantigen Targeted Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Neoantigen Targeted Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
BioNTech SE
Gritstone Bio
Genocea Biosciences
Moderna
Agenus
Immatics
Advaxis
Precision Biologics
Gilead Sciences
Cellular Biomedicine Group
Achilles Therapeutics
Merck and Co
Beijing Kati Medical Technology
Segment by Type
Off-the-shelf Neoantigen
Personalized Neoantigen
Segment by Application
Colorectal Cancer
Renal Cell Carcinoma
Non-Small Cell Lung cancer
Bone Cancer
Gynecological Cancer
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Neoantigen Targeted Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Neoantigen Targeted Therapy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Off-the-shelf Neoantigen
1.2.3 Personalized Neoantigen
1.3 Market by Application
1.3.1 Global Neoantigen Targeted Therapy Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Colorectal Cancer
1.3.3 Renal Cell Carcinoma
1.3.4 Non-Small Cell Lung cancer
1.3.5 Bone Cancer
1.3.6 Gynecological Cancer
1.3.7 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Neoantigen Targeted Therapy Market Perspective (2020-2031)
2.2 Global Neoantigen Targeted Therapy Growth Trends by Region
2.2.1 Global Neoantigen Targeted Therapy Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Neoantigen Targeted Therapy Historic Market Size by Region (2020-2025)
2.2.3 Neoantigen Targeted Therapy Forecasted Market Size by Region (2026-2031)
2.3 Neoantigen Targeted Therapy Market Dynamics
2.3.1 Neoantigen Targeted Therapy Industry Trends
2.3.2 Neoantigen Targeted Therapy Market Drivers
2.3.3 Neoantigen Targeted Therapy Market Challenges
2.3.4 Neoantigen Targeted Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Neoantigen Targeted Therapy Players by Revenue
3.1.1 Global Top Neoantigen Targeted Therapy Players by Revenue (2020-2025)
3.1.2 Global Neoantigen Targeted Therapy Revenue Market Share by Players (2020-2025)
3.2 Global Neoantigen Targeted Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Neoantigen Targeted Therapy Revenue
3.4 Global Neoantigen Targeted Therapy Market Concentration Ratio
3.4.1 Global Neoantigen Targeted Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Neoantigen Targeted Therapy Revenue in 2024
3.5 Global Key Players of Neoantigen Targeted Therapy Head office and Area Served
3.6 Global Key Players of Neoantigen Targeted Therapy, Product and Application
3.7 Global Key Players of Neoantigen Targeted Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Neoantigen Targeted Therapy Breakdown Data by Type
4.1 Global Neoantigen Targeted Therapy Historic Market Size by Type (2020-2025)
4.2 Global Neoantigen Targeted Therapy Forecasted Market Size by Type (2026-2031)
5 Neoantigen Targeted Therapy Breakdown Data by Application
5.1 Global Neoantigen Targeted Therapy Historic Market Size by Application (2020-2025)
5.2 Global Neoantigen Targeted Therapy Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Neoantigen Targeted Therapy Market Size (2020-2031)
6.2 North America Neoantigen Targeted Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Neoantigen Targeted Therapy Market Size by Country (2020-2025)
6.4 North America Neoantigen Targeted Therapy Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Neoantigen Targeted Therapy Market Size (2020-2031)
7.2 Europe Neoantigen Targeted Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Neoantigen Targeted Therapy Market Size by Country (2020-2025)
7.4 Europe Neoantigen Targeted Therapy Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Neoantigen Targeted Therapy Market Size (2020-2031)
8.2 Asia-Pacific Neoantigen Targeted Therapy Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Neoantigen Targeted Therapy Market Size by Region (2020-2025)
8.4 Asia-Pacific Neoantigen Targeted Therapy Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Neoantigen Targeted Therapy Market Size (2020-2031)
9.2 Latin America Neoantigen Targeted Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Neoantigen Targeted Therapy Market Size by Country (2020-2025)
9.4 Latin America Neoantigen Targeted Therapy Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Neoantigen Targeted Therapy Market Size (2020-2031)
10.2 Middle East & Africa Neoantigen Targeted Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Neoantigen Targeted Therapy Market Size by Country (2020-2025)
10.4 Middle East & Africa Neoantigen Targeted Therapy Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 BioNTech SE
11.1.1 BioNTech SE Company Details
11.1.2 BioNTech SE Business Overview
11.1.3 BioNTech SE Neoantigen Targeted Therapy Introduction
11.1.4 BioNTech SE Revenue in Neoantigen Targeted Therapy Business (2020-2025)
11.1.5 BioNTech SE Recent Development
11.2 Gritstone Bio
11.2.1 Gritstone Bio Company Details
11.2.2 Gritstone Bio Business Overview
11.2.3 Gritstone Bio Neoantigen Targeted Therapy Introduction
11.2.4 Gritstone Bio Revenue in Neoantigen Targeted Therapy Business (2020-2025)
11.2.5 Gritstone Bio Recent Development
11.3 Genocea Biosciences
11.3.1 Genocea Biosciences Company Details
11.3.2 Genocea Biosciences Business Overview
11.3.3 Genocea Biosciences Neoantigen Targeted Therapy Introduction
11.3.4 Genocea Biosciences Revenue in Neoantigen Targeted Therapy Business (2020-2025)
11.3.5 Genocea Biosciences Recent Development
11.4 Moderna
11.4.1 Moderna Company Details
11.4.2 Moderna Business Overview
11.4.3 Moderna Neoantigen Targeted Therapy Introduction
11.4.4 Moderna Revenue in Neoantigen Targeted Therapy Business (2020-2025)
11.4.5 Moderna Recent Development
11.5 Agenus
11.5.1 Agenus Company Details
11.5.2 Agenus Business Overview
11.5.3 Agenus Neoantigen Targeted Therapy Introduction
11.5.4 Agenus Revenue in Neoantigen Targeted Therapy Business (2020-2025)
11.5.5 Agenus Recent Development
11.6 Immatics
11.6.1 Immatics Company Details
11.6.2 Immatics Business Overview
11.6.3 Immatics Neoantigen Targeted Therapy Introduction
11.6.4 Immatics Revenue in Neoantigen Targeted Therapy Business (2020-2025)
11.6.5 Immatics Recent Development
11.7 Advaxis
11.7.1 Advaxis Company Details
11.7.2 Advaxis Business Overview
11.7.3 Advaxis Neoantigen Targeted Therapy Introduction
11.7.4 Advaxis Revenue in Neoantigen Targeted Therapy Business (2020-2025)
11.7.5 Advaxis Recent Development
11.8 Precision Biologics
11.8.1 Precision Biologics Company Details
11.8.2 Precision Biologics Business Overview
11.8.3 Precision Biologics Neoantigen Targeted Therapy Introduction
11.8.4 Precision Biologics Revenue in Neoantigen Targeted Therapy Business (2020-2025)
11.8.5 Precision Biologics Recent Development
11.9 Gilead Sciences
11.9.1 Gilead Sciences Company Details
11.9.2 Gilead Sciences Business Overview
11.9.3 Gilead Sciences Neoantigen Targeted Therapy Introduction
11.9.4 Gilead Sciences Revenue in Neoantigen Targeted Therapy Business (2020-2025)
11.9.5 Gilead Sciences Recent Development
11.10 Cellular Biomedicine Group
11.10.1 Cellular Biomedicine Group Company Details
11.10.2 Cellular Biomedicine Group Business Overview
11.10.3 Cellular Biomedicine Group Neoantigen Targeted Therapy Introduction
11.10.4 Cellular Biomedicine Group Revenue in Neoantigen Targeted Therapy Business (2020-2025)
11.10.5 Cellular Biomedicine Group Recent Development
11.11 Achilles Therapeutics
11.11.1 Achilles Therapeutics Company Details
11.11.2 Achilles Therapeutics Business Overview
11.11.3 Achilles Therapeutics Neoantigen Targeted Therapy Introduction
11.11.4 Achilles Therapeutics Revenue in Neoantigen Targeted Therapy Business (2020-2025)
11.11.5 Achilles Therapeutics Recent Development
11.12 Merck and Co
11.12.1 Merck and Co Company Details
11.12.2 Merck and Co Business Overview
11.12.3 Merck and Co Neoantigen Targeted Therapy Introduction
11.12.4 Merck and Co Revenue in Neoantigen Targeted Therapy Business (2020-2025)
11.12.5 Merck and Co Recent Development
11.13 Beijing Kati Medical Technology
11.13.1 Beijing Kati Medical Technology Company Details
11.13.2 Beijing Kati Medical Technology Business Overview
11.13.3 Beijing Kati Medical Technology Neoantigen Targeted Therapy Introduction
11.13.4 Beijing Kati Medical Technology Revenue in Neoantigen Targeted Therapy Business (2020-2025)
11.13.5 Beijing Kati Medical Technology Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Neoantigen Targeted Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Off-the-shelf Neoantigen
Table 3. Key Players of Personalized Neoantigen
Table 4. Global Neoantigen Targeted Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Neoantigen Targeted Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Neoantigen Targeted Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Neoantigen Targeted Therapy Market Share by Region (2020-2025)
Table 8. Global Neoantigen Targeted Therapy Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Neoantigen Targeted Therapy Market Share by Region (2026-2031)
Table 10. Neoantigen Targeted Therapy Market Trends
Table 11. Neoantigen Targeted Therapy Market Drivers
Table 12. Neoantigen Targeted Therapy Market Challenges
Table 13. Neoantigen Targeted Therapy Market Restraints
Table 14. Global Neoantigen Targeted Therapy Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Neoantigen Targeted Therapy Market Share by Players (2020-2025)
Table 16. Global Top Neoantigen Targeted Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neoantigen Targeted Therapy as of 2024)
Table 17. Ranking of Global Top Neoantigen Targeted Therapy Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Neoantigen Targeted Therapy Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Neoantigen Targeted Therapy, Headquarters and Area Served
Table 20. Global Key Players of Neoantigen Targeted Therapy, Product and Application
Table 21. Global Key Players of Neoantigen Targeted Therapy, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Neoantigen Targeted Therapy Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Neoantigen Targeted Therapy Revenue Market Share by Type (2020-2025)
Table 25. Global Neoantigen Targeted Therapy Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Neoantigen Targeted Therapy Revenue Market Share by Type (2026-2031)
Table 27. Global Neoantigen Targeted Therapy Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Neoantigen Targeted Therapy Revenue Market Share by Application (2020-2025)
Table 29. Global Neoantigen Targeted Therapy Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Neoantigen Targeted Therapy Revenue Market Share by Application (2026-2031)
Table 31. North America Neoantigen Targeted Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Neoantigen Targeted Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Neoantigen Targeted Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Neoantigen Targeted Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Neoantigen Targeted Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Neoantigen Targeted Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Neoantigen Targeted Therapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Neoantigen Targeted Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Neoantigen Targeted Therapy Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Neoantigen Targeted Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Neoantigen Targeted Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Neoantigen Targeted Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Neoantigen Targeted Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Neoantigen Targeted Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Neoantigen Targeted Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 46. BioNTech SE Company Details
Table 47. BioNTech SE Business Overview
Table 48. BioNTech SE Neoantigen Targeted Therapy Product
Table 49. BioNTech SE Revenue in Neoantigen Targeted Therapy Business (2020-2025) & (US$ Million)
Table 50. BioNTech SE Recent Development
Table 51. Gritstone Bio Company Details
Table 52. Gritstone Bio Business Overview
Table 53. Gritstone Bio Neoantigen Targeted Therapy Product
Table 54. Gritstone Bio Revenue in Neoantigen Targeted Therapy Business (2020-2025) & (US$ Million)
Table 55. Gritstone Bio Recent Development
Table 56. Genocea Biosciences Company Details
Table 57. Genocea Biosciences Business Overview
Table 58. Genocea Biosciences Neoantigen Targeted Therapy Product
Table 59. Genocea Biosciences Revenue in Neoantigen Targeted Therapy Business (2020-2025) & (US$ Million)
Table 60. Genocea Biosciences Recent Development
Table 61. Moderna Company Details
Table 62. Moderna Business Overview
Table 63. Moderna Neoantigen Targeted Therapy Product
Table 64. Moderna Revenue in Neoantigen Targeted Therapy Business (2020-2025) & (US$ Million)
Table 65. Moderna Recent Development
Table 66. Agenus Company Details
Table 67. Agenus Business Overview
Table 68. Agenus Neoantigen Targeted Therapy Product
Table 69. Agenus Revenue in Neoantigen Targeted Therapy Business (2020-2025) & (US$ Million)
Table 70. Agenus Recent Development
Table 71. Immatics Company Details
Table 72. Immatics Business Overview
Table 73. Immatics Neoantigen Targeted Therapy Product
Table 74. Immatics Revenue in Neoantigen Targeted Therapy Business (2020-2025) & (US$ Million)
Table 75. Immatics Recent Development
Table 76. Advaxis Company Details
Table 77. Advaxis Business Overview
Table 78. Advaxis Neoantigen Targeted Therapy Product
Table 79. Advaxis Revenue in Neoantigen Targeted Therapy Business (2020-2025) & (US$ Million)
Table 80. Advaxis Recent Development
Table 81. Precision Biologics Company Details
Table 82. Precision Biologics Business Overview
Table 83. Precision Biologics Neoantigen Targeted Therapy Product
Table 84. Precision Biologics Revenue in Neoantigen Targeted Therapy Business (2020-2025) & (US$ Million)
Table 85. Precision Biologics Recent Development
Table 86. Gilead Sciences Company Details
Table 87. Gilead Sciences Business Overview
Table 88. Gilead Sciences Neoantigen Targeted Therapy Product
Table 89. Gilead Sciences Revenue in Neoantigen Targeted Therapy Business (2020-2025) & (US$ Million)
Table 90. Gilead Sciences Recent Development
Table 91. Cellular Biomedicine Group Company Details
Table 92. Cellular Biomedicine Group Business Overview
Table 93. Cellular Biomedicine Group Neoantigen Targeted Therapy Product
Table 94. Cellular Biomedicine Group Revenue in Neoantigen Targeted Therapy Business (2020-2025) & (US$ Million)
Table 95. Cellular Biomedicine Group Recent Development
Table 96. Achilles Therapeutics Company Details
Table 97. Achilles Therapeutics Business Overview
Table 98. Achilles Therapeutics Neoantigen Targeted Therapy Product
Table 99. Achilles Therapeutics Revenue in Neoantigen Targeted Therapy Business (2020-2025) & (US$ Million)
Table 100. Achilles Therapeutics Recent Development
Table 101. Merck and Co Company Details
Table 102. Merck and Co Business Overview
Table 103. Merck and Co Neoantigen Targeted Therapy Product
Table 104. Merck and Co Revenue in Neoantigen Targeted Therapy Business (2020-2025) & (US$ Million)
Table 105. Merck and Co Recent Development
Table 106. Beijing Kati Medical Technology Company Details
Table 107. Beijing Kati Medical Technology Business Overview
Table 108. Beijing Kati Medical Technology Neoantigen Targeted Therapy Product
Table 109. Beijing Kati Medical Technology Revenue in Neoantigen Targeted Therapy Business (2020-2025) & (US$ Million)
Table 110. Beijing Kati Medical Technology Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
Table 114. Authors List of This Report


List of Figures
Figure 1. Neoantigen Targeted Therapy Picture
Figure 2. Global Neoantigen Targeted Therapy Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Neoantigen Targeted Therapy Market Share by Type: 2024 VS 2031
Figure 4. Off-the-shelf Neoantigen Features
Figure 5. Personalized Neoantigen Features
Figure 6. Global Neoantigen Targeted Therapy Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Neoantigen Targeted Therapy Market Share by Application: 2024 VS 2031
Figure 8. Colorectal Cancer Case Studies
Figure 9. Renal Cell Carcinoma Case Studies
Figure 10. Non-Small Cell Lung cancer Case Studies
Figure 11. Bone Cancer Case Studies
Figure 12. Gynecological Cancer Case Studies
Figure 13. Others Case Studies
Figure 14. Neoantigen Targeted Therapy Report Years Considered
Figure 15. Global Neoantigen Targeted Therapy Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global Neoantigen Targeted Therapy Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Neoantigen Targeted Therapy Market Share by Region: 2024 VS 2031
Figure 18. Global Neoantigen Targeted Therapy Market Share by Players in 2024
Figure 19. Global Top Neoantigen Targeted Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neoantigen Targeted Therapy as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by Neoantigen Targeted Therapy Revenue in 2024
Figure 21. North America Neoantigen Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America Neoantigen Targeted Therapy Market Share by Country (2020-2031)
Figure 23. United States Neoantigen Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada Neoantigen Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Neoantigen Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Neoantigen Targeted Therapy Market Share by Country (2020-2031)
Figure 27. Germany Neoantigen Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France Neoantigen Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. Neoantigen Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy Neoantigen Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia Neoantigen Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries Neoantigen Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Neoantigen Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Neoantigen Targeted Therapy Market Share by Region (2020-2031)
Figure 35. China Neoantigen Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan Neoantigen Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea Neoantigen Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia Neoantigen Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India Neoantigen Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia Neoantigen Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Neoantigen Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Neoantigen Targeted Therapy Market Share by Country (2020-2031)
Figure 43. Mexico Neoantigen Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil Neoantigen Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Neoantigen Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Neoantigen Targeted Therapy Market Share by Country (2020-2031)
Figure 47. Turkey Neoantigen Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia Neoantigen Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE Neoantigen Targeted Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. BioNTech SE Revenue Growth Rate in Neoantigen Targeted Therapy Business (2020-2025)
Figure 51. Gritstone Bio Revenue Growth Rate in Neoantigen Targeted Therapy Business (2020-2025)
Figure 52. Genocea Biosciences Revenue Growth Rate in Neoantigen Targeted Therapy Business (2020-2025)
Figure 53. Moderna Revenue Growth Rate in Neoantigen Targeted Therapy Business (2020-2025)
Figure 54. Agenus Revenue Growth Rate in Neoantigen Targeted Therapy Business (2020-2025)
Figure 55. Immatics Revenue Growth Rate in Neoantigen Targeted Therapy Business (2020-2025)
Figure 56. Advaxis Revenue Growth Rate in Neoantigen Targeted Therapy Business (2020-2025)
Figure 57. Precision Biologics Revenue Growth Rate in Neoantigen Targeted Therapy Business (2020-2025)
Figure 58. Gilead Sciences Revenue Growth Rate in Neoantigen Targeted Therapy Business (2020-2025)
Figure 59. Cellular Biomedicine Group Revenue Growth Rate in Neoantigen Targeted Therapy Business (2020-2025)
Figure 60. Achilles Therapeutics Revenue Growth Rate in Neoantigen Targeted Therapy Business (2020-2025)
Figure 61. Merck and Co Revenue Growth Rate in Neoantigen Targeted Therapy Business (2020-2025)
Figure 62. Beijing Kati Medical Technology Revenue Growth Rate in Neoantigen Targeted Therapy Business (2020-2025)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies